ReviewAllergy, asthma & immunology research2025
Prevention of Atopic Dermatitis: What Are We Missing?
Review in Allergy, asthma & immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atopic dermatitis (AD) is a prevalent chronic inflammatory disease that significantly burdens individuals and healthcare systems worldwide. The incidence of AD has risen sharply in both developed and emerging economies, necessitating an understanding of its complex etiological factors, including environmental influences and lifestyle changes. Generally, 2 primary preventive strategies for AD have been implemented so far: (1) the "Inside Out" approach that which involves allergen elimination, probiotic supplementation, fish oil supplementation, and vitamin D supplementation aim to regulate the immune system in pregnancy and early childhood and (2) the "Outside In" approach that focuses on improving skin barrier function through emollient use and environmental changes. Although current evidence suggests the potential benefits from these interventions, randomized controlled trials have revealed inconsistencies in their efficacy. It is imperative not only to explore the minute research gaps in existing studies, but also to develop novel interventional studies that consider individual and regional differences based on the epithelial barrier hypothesis, the biodiversity hypothesis, and the 'old friends' hypothesis evolved from the hygiene hypothesis. Ultimately, reversing the rising trend of AD prevalence will most likely require a multifaceted approach that integrates new scientific evidence and promote comprehensive lifestyle changes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.